Volume 8 Issue 143
Published - 14:00 UTC 08:00 EST 23-May-2006 
Next Update - 14:00 UTC 08:00 EST 24-May-2006

Editor: Susan K. Boyer, RN
All rights reserved.

HONcode accreditation seal. We subscribe to the HONcode principles.
Verify here



Personalized treatment trial for breast cancer launched

The Trial Assigning IndividuaLized Options for Treatment (Rx), or TAILORx, was launched today to examine whether genes that are frequently associated with risk of recurrence for women with early-stage breast cancer can be used to assign patients to the most appropriate and effective treatment. TAILORx is sponsored by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), and is coordinated by the Eastern Cooperative Oncology Group (ECOG). more  

NIAID study finds higher dose of flu vaccine improves immune response in the elderly

There may be a simple way to provide elderly Americans with extra protection against the annual flu virus: give them a higher dose of seasonal flu vaccine. This idea is suggested by the results of a newly reported clinical trial supported by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). more

For patients with severe lung injury, less is more

Results from the largest controlled clinical trial of fluid management methods in patients with severe lung injury provide important new information on the risks and benefits of patient care strategies currently used in the intensive care unit. The two studies that comprised the trial showed that for patients with acute lung injury or its more severe form, acute respiratory distress syndrome, less fluid is better than more, and a shorter, less invasive catheter is as helpful as and safer than a longer catheter for monitoring patients. The trial was conducted by scientists from the Acute Respiratory Distress Syndrome Clinical Research Network of the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health. more  

New research shows vaccine may offer promising treatment for nicotine addiction

Each year nearly half of all smokers attempt to quit smoking, but less than 5 percent are successful beyond 3 months to a year. Results from a new study by Dr. Dorothy Hatsukami and colleagues from the University of Minnesota Medical School suggest a new nicotine vaccine may be safe and effective in helping smokers who want to quit. more

Psychiatrists should be more alert to smoking practices among patients in routine care 

Results of a recently published study suggest that psychiatrists tend to significantly underreport patients who smoke and undertreat their smoking problem. This finding, say the scientists who conducted the research, is important because psychiatric patients who smoke are likely to have greater psychosocial needs than those who do not. more

Numerous factors influence chronic smoking in youth, and many cross racial, ethnic lines  

Having parents or friends who smoke, dropping out of high school, and trying cigarettes at a young age are among the factors that are linked to adolescents being more likely to become chronic smokers, according to new research supported in part by NIDA. more

Schizophrenics take in more nicotine per cigarette

Smokers with schizophrenia and related disorders take in more nicotine per cigarette than people without such mental illnesses, suggesting that such diseases have a neurobiological component that drives people to seek out the drug. This, in turn, indicates that effective treatment for tobacco addiction for people with schizophrenia might include nicotine replacement treatments that mimic smoking behavior. more


Results of a recently published study suggest that psychiatrists tend to significantly underreport patients who smoke and undertreat their smoking problem.